Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cimetidine 200mg/2ml solution for injection ampoules
0103010D0AAAEAE
|
Cimetidine | Cimetidine | Gastro-Intestinal System | No data available |
|
Cimetidine 200mg/5ml oral suspension sugar free
0103010D0AAAGAG
|
Cimetidine | Cimetidine | Gastro-Intestinal System | No data available |
|
Cimetidine 400mg effervescent tablets sugar free
0103010D0AAAIAI
|
Cimetidine | Cimetidine | Gastro-Intestinal System | No data available |
|
Cinchocaine 1.1% ointment
0107010G0AAAAAA
|
Cinchocaine hydrochloride | Cinchocaine hydrochloride | Gastro-Intestinal System | No data available |
|
Cisapride 10mg tablets
0102000G0AAAAAA
|
Cisapride | Cisapride | Gastro-Intestinal System | No data available |
|
Cisapride 5mg/5ml oral suspension
0102000G0AAADAD
|
Cisapride | Cisapride | Gastro-Intestinal System | No data available |
|
CitraFleet oral powder 16.11g sachets
0106050S0BCAAA0
|
CitraFleet | Sodium picosulfate | Gastro-Intestinal System | No data available |
|
Co-danthramer 25mg/200mg capsules
0106020B0AAACAC
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
|
Co-danthramer 25mg/200mg/5ml oral suspension
0106020B0AAAHAH
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
|
Co-danthramer 37.5mg/500mg capsules
0106020B0AAAFAF
|
Co-danthramer | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
|
Co-magaldrox 300mg/600mg tablets
0101010G0AAADAD
|
Co-magaldrox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | No data available |
|
Co-magaldrox 300mg/600mg/5ml oral suspension sugar free
0101010G0AAACAC
|
Co-magaldrox | Co-magaldrox (Magnesium/aluminium hydroxide) | Gastro-Intestinal System | No data available |
|
Coalgicarb oral suspension
0101021B0BKAAAH
|
Coalgicarb | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Colofac 100 tablets
0102000P0BCADAC
|
Colofac | Mebeverine hydrochloride | Gastro-Intestinal System | No data available |
|
Colofac 50mg/5ml liquid
0102000P0BCAAAA
|
Colofac | Mebeverine hydrochloride | Gastro-Intestinal System | No data available |
|
Cream of Magnesia 300mg chewable tablets
0101010Q0BCAAAB
|
Cream of Magnesia (Antacid) | Magnesium hydroxide | Gastro-Intestinal System | No data available |
|
Creon 750mg gastro-resistant granules sachets
0109040N0BDACAR
|
Creon | Pancreatin | Gastro-Intestinal System | No data available |
|
Danlax oral suspension
0106020B0BEAAAH
|
Danlax | Co-danthramer (Dantron/poloxamer 188) | Gastro-Intestinal System | No data available |
|
De-Noltab 120mg tablets
0103030W0BBAAAA
|
De-Noltab | Tripotassium dicitratobismuthate | Gastro-Intestinal System | No data available |
|
Deoxxa 250mg/5ml oral suspension
0109010U0BHAABE
|
Deoxxa | Ursodeoxycholic acid | Gastro-Intestinal System | No data available |
|
Diah-Limit 2mg capsules
0104020L0BLAAAA
|
Diah-Limit | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Diaquitte 2mg capsules
0104020L0BRAAAA
|
Diaquitte | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Diareze Diarrhoea Relief 2mg capsules
0104020L0BCAAAA
|
Diareze (Diarrhoea) | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Diasorb 2mg capsules
0104020L0BHAAAA
|
Diasorb | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Diltiazem 0.4% cream
0107010AAAAAIAI
|
Diltiazem hydrochloride (Haemorrhoids) | Diltiazem hydrochloride | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.